NB-001(Zhejiang Yongzhan)

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameNB-001(Zhejiang Yongzhan)
Drug Alias NameNB-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulatorsBrain adenylate cyclase 1 inhibitors
TargetsBrain adenylate cyclase 1
Therapy Area/IndicationsCancer PainMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsCancer Pain

Other Information

ATC CodeN/A
Related LinksN/A